ACE gene polymorphism as a prognostic indicator in patients with type 2 diabetes and established renal disease

Diabetes Care. 2001 Dec;24(12):2115-20. doi: 10.2337/diacare.24.12.2115.

Abstract

Objective: To investigate whether the DD genotype is a predictor of mortality and of the decline in renal function in patients with type 2 diabetes and established nephropathy.

Research design and methods: A total of 56 such patients of Maltese Caucasian descent were recruited, and their ACE genotype was determined. Serum creatinine was estimated approximately every 4 months. The glomerular filtration rate (GFR) was calculated according to the Cockroft-Gault formula, and rate of change was determined by regression analysis.

Results: The rate of change in calculated GFR was -7.76 ml.min(-1).year(-1) in those with the DD genotype (n = 31) and -1.17 ml. min(-1). h(-1) in those with the ID or II genotype (n = 25) (P < 0.01). The 3-year mortality was 45.2% in the DD group compared with 20.0% in the ID/II group (P < 0.05).

Conclusions: The DD genotype of the ACE gene polymorphism is associated with a more rapid decline in renal function and higher mortality in type 2 diabetic patients with established nephropathy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Diabetes Mellitus, Type 2 / enzymology
  • Diabetes Mellitus, Type 2 / genetics*
  • Diabetes Mellitus, Type 2 / mortality
  • Diabetic Nephropathies / enzymology
  • Diabetic Nephropathies / genetics*
  • Diabetic Nephropathies / physiopathology
  • Female
  • Genotype
  • Glomerular Filtration Rate
  • Glycated Hemoglobin / analysis
  • Humans
  • Male
  • Middle Aged
  • Peptidyl-Dipeptidase A / genetics*
  • Polymorphism, Genetic*
  • Prognosis
  • Survival Rate

Substances

  • Glycated Hemoglobin A
  • Peptidyl-Dipeptidase A